December 26, 2012
BD Completes Acquisition of Safety Syringes, Inc.
|
December 21, 2012
BD to Present at Investor Healthcare Conferences
|
December 10, 2012
Medication Errors from Injectable Drugs Harm One Million Inpatients Each Year Adding Billions in Cost, New Study Finds
|
November 20, 2012
BD Board Increases Dividend by 10 Percent
|
November 07, 2012
BD Announces Results for 2012 Fourth Fiscal Quarter and Full Year
|
November 06, 2012
BD Announces Funding and Product Support for Hurricane Sandy Relief Efforts
|
November 06, 2012
BD Announces Appointment of William A. Kozy as Chief Operating Officer
|
November 01, 2012
BD Completes Sale of Majority of Discovery Labware Unit
|
October 31, 2012
First Partner Assay on the BD MAX™ System Launches in Europe
|
October 29, 2012
BD is Awarded WindMade™ Certification; Ranks Among Top 40 U.S. Companies in Newsweek's 2012 Green Rankings
|
October 17, 2012
New Molecular Test Available to Diagnose Trichomonas vaginalis in Asymptomatic and Symptomatic Females
|
October 12, 2012
BD and Lab21 Collaborate to Develop New Oncology Assays on the BD MAX™ Platform
|
October 11, 2012
New Disposable Pen Injector Offers Ease of Use as well as Customization Options for Use with a Wide Range of Injectable Drugs
|
October 10, 2012
BD Announces Chief Financial Officer Transition
|
October 02, 2012
New RSV Test Provides Reliable Results in Minutes
|
October 02, 2012
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call
|
September 28, 2012
Leading Microbiology Expert Joins BD Diagnostics in Maryland
|
September 26, 2012
New Molecular Assay Detects Rapidly Emerging Multidrug-Resistant Superbug
|
September 20, 2012
New Influenza Test Offers Labs Advanced Performance and Reliable Results
|
September 19, 2012
BD Introduces Advanced Needle Technology Designed to Enhance Patient Comfort and Improve Patient Adherence in Diabetes Care
|
September 04, 2012
New Initiative to Advance Health Workers' Blood Collection Skills
|
August 27, 2012
BD Acquires Sirigen Group Limited
|
August 14, 2012
New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
|
August 02, 2012
BD Announces Results for 2012 Third Fiscal Quarter
|
July 26, 2012
BD and PEPFAR Launch Labs for Life to Strengthen Laboratories in Regions Heavily Burdened by Disease
|
July 25, 2012
BD Launches New Needle Designed to Improve Performance and Patient Comfort
|
July 24, 2012
BD Board Declares Dividend
|
July 23, 2012
BD Board of Directors Elects Rebecca W. Rimel
|
July 16, 2012
New Plastic Blood Culture Bottles Increase Lab Convenience While Maintaining High-Quality Standards
|
July 11, 2012
BD Announces Agreement to Acquire Safety Syringes, Inc.
|
July 09, 2012
New, Fully Automated BD MAX™ MRSA Assay Rapidly Identifies Patients Colonized with Deadly Superbug
|
June 28, 2012
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
June 20, 2012
New, Affordable Flow Cytometer Cell Sorter Expands Access to Wider Range of Life Science Applications
|
June 07, 2012
JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
|
May 30, 2012
BD to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
|
May 23, 2012
BD Issues 2011 Sustainability Report
|
May 22, 2012
BD Board Declares Dividend
|
May 22, 2012
BD Appoints CEO Vincent A. Forlenza as Chairman of the Board
|
May 21, 2012
BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti
|
May 02, 2012
BD Opens Major Distribution Center in Four Oaks, North Carolina
|
May 02, 2012
BD to Present at Investor Healthcare Conferences
|
May 01, 2012
BD Announces Results for 2012 Second Fiscal Quarter
|
April 10, 2012
BD Signs Agreement to Sell Majority of Discovery Labware Unit
Advanced Bioprocessing Platform Excluded from Sale
|
April 02, 2012
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 29, 2012
New Assay Rapidly Identifies Lethal Pathogen Responsible for Clostridium difficile Infection
|
March 27, 2012
New IVD Product is Designed to Improve Prevention and Control of GBS in Newborns
|
March 26, 2012
New Collaboration Aims to Improve Access to TB Diagnostics
|
March 09, 2012
BD to Present at the Barclays Capital Global Healthcare Conference
|
March 07, 2012
Study Shows Nurses are Exposed To Risks from Blood Exposure During Insertion and Removal of Peripheral IV Catheter
|
March 01, 2012
Nationwide Educational Tour Kicks Off on the Future of Molecular Diagnostics
|
February 13, 2012
BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies to Offer Integrated Microbiology Lab Solutions
|
February 13, 2012
BD Acquires KIESTRA Lab Automation BV
|
February 13, 2012
First Specimen Collection Training Curriculum in Sub-Saharan Africa Launches at Kenyan Medical Training College
|
February 10, 2012
BD to Present at Investor Healthcare Conferences
|
February 07, 2012
Mesenchymal Stem Cells Have New Cell Culture Environment
|
February 06, 2012
BD Announces Results for 2012 First Fiscal Quarter
|
January 31, 2012
BD Board Declares Dividend
|
January 24, 2012
BD Announces Webcast of Annual Meeting of Shareholders
|
January 18, 2012
BD and Mercy/ROi Collaborate to Improve Quality of Care and Reduce Costs
|
January 11, 2012
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
January 04, 2012
BD to Present at the 30th Annual J. P. Morgan Healthcare Conference
|
